U

MitoCareX Bio

Novel Therapies for Hard-to-treat Resistant Cancers
Startup Acquired Founded 2022 Health Tech & Life Sciences
Last Update Aug 5, 2025

MitoCareX Bio Business

Business models
Product stage
R&D
Employees
1-10

Sector

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Target Customer

Healthcare & Life SciencesLife SciencesPharmaceuticals

Core Technology

BiologicalsMolecules

Tags (4)

pharmaceuticalscancercancer-therapyoncology